Rat brain pro-oxidant effects of peripherally administered 5nm ceria 30 days after exposure

NeuroToxicology

Volumn 33, Issue 5, 2012, Pages 1147-1155

  Hardas, Sarita S ^a   Sultana, Rukhsana ^a   Warrier, Govind ^a   Dan, Mo ^a   Florence, Rebecca L ^a   Wu, Peng ^b   Grulke, Eric A ^b   Tseng, Michael T ^c   Unrine, Jason M ^d   Graham, Uschi M ^a   Yokel, Robert A ^a   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Brain; Ceria; Nanomaterial; Nanoparticles; Neurotoxicity; Oxidative stress; Rat

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; CARBONYL DERIVATIVE; CATALASE; CERIUM OXIDE; CITRIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; NANOMATERIAL; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISPERSION; ELECTRON ENERGY LOSS SPECTROSCOPY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; MASS SPECTROMETRY; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; BRAIN; CERIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HSP70 HEAT-SHOCK PROTEINS; MALE; MASS SPECTROMETRY; MICROSCOPY, ELECTRON; NANOSTRUCTURES; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, ELECTRON ENERGY-LOSS; SUPEROXIDE DISMUTASE; TYROSINE;

MAMMALIA; RATTUS;

EID: 84867232585     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.06.007     Document Type: Article

References (59)

1. Ahamed M., Posgai R., Gorey T.J., Nielsen M., Hussain S.M., Rowe J.J. Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicol Appl Pharmacol 2010, 242(3):263-269.
2. Akhtar M.J., Ahamed M., Kumar S., Siddiqui H., Patil G., Ashquin M., et al. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology 2010, 276(2):95-102.
3. Amin K.A., Hassan M.S., Awad el-ST, Hashem K.S. The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomed 2011, 6:143-149.
4. 2 nanoparticles induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 2009, 3(2):161-171.
5. Babu S., Cho J.-H., Dowding J.M., Heckert E., Komanski C., Das S., et al. Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics. Chem Commun 2010, 46(37):6915-6917.
6. Bhabra G., Sood A., Fisher B., Cartwright L., Saunders M., Evans W.H., et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009, 4(12):876-883.
7. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40(14):4374-4381.
8. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role of amyloid β-peptide. Trends Mol Med 2001, 7:548-554.
9. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 1997, 2:161-191.
10. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid [beta]-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007, 43(5):658-677.
11. Calabrese V., Bates T.E., Stella A.M.G. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem Res 2000, 25(9-10):1315-1341.
12. Celardo I., Pedersen J.Z., Traversa E., Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale 2011, 3(4):1411-1420.
13. Chen J.P., Patil S., Seal S., McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006, 1(2):142-150.
14. Cho W.-S., Duffin R., Poland C.A., Howie S.E.M., MacNee W., Bradley M., et al. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 2010, 118(12):1699-1706.
15. Choi J., Reipa V., Hitchins V.M., Goering P.L., Malinauskas R.A. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 2011, 123(1):133-143.
16. Colon J., Hsieh N., Ferguson A., Kupelian P., Seal S., Jenkins D.W., et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomed Nanotechnol Biol Med 2010, 6(5):698-705.
17. D'Angelo B., Santucci S., Benedetti E., Di Loreto S., Phani R.A., Falone S., et al. Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr Nanosci 2009, 5(2):167-176.
18. Das M., Patil S., Bhargava N., Kang J.F., Riedel L.M., Seal S., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28(10):1918-1925.
19. Donaldson K., Stone V., Tran C.L., Kreyling W., Borm P.J.A. Nanotoxicology. Occup Environ Med 2004, 61(9):727-728.
20. Estevez A.Y., Pritchard S., Harper K., Aston J.W., Lynch A., Lucky J.J., et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 2011, 51(6):1155-1163.
21. Fubini B., Ghiazza M., Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 2010, 4(4):347-363.
22. Gilliss S.R., Bentley J., Carter C.B. Electron energy-loss spectroscopic study of the surface of ceria abrasives. Appl Surf Sci 2005, 241(1-2):61-67.
23. Guo Y.-Y., Zhang J., Zheng Y.-F., Yang J., Zhu X.-Q. Cytotoxic and genotoxic effects of multi-wall carbon nanotubes on human umbilical vein endothelial cells in vitro. Mutat Res: Genet Toxicol Environ Mutagen 2011, 721(2):184-191.
24. Halliwell B. Reactive oxygen species and the central-nervous-system. J Neurochem 1992, 59(5):1609-1623.
25. 2 nanoparticles on oxidative stress and histopathological changes in Juvenile Carp (Cyprinus carpio). J Environ Sci 2009, 21(10):1459-1466.
26. Hardas S.S., Butterfield D.A., Sultana R., Tseng M.T., Dan M., Florence R.L., et al. Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria. Toxicol Sci 2010, 116(2):562-576.
27. Hirst S.M., Karakoti A., Singh S., Self W., Tyler R., Seal S., et al. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 2011, 10.1002/tox.20704.
28. Hirst S.M., Karakoti A.S., Tyler R.D., Sriranganathan N., Seal S., Reilly C.M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009, 5(24):2848-2856.
29. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976, 74(1):214-226.
30. Korsvik C., Patil S., Seal S., Self W.T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun 2007, (10):1056-1058.
31. Landsiedel R., Kapp M.D., Schulz M., Wiench K., Oesch F. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations-many questions, some answers. Mutat Res: Rev Mutat Res 2009, 681(2-3):241-258.
32. Liang G., Pu Y., Yin L., Liu R., Ye B., Su Y., et al. Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. J Toxicol Environ Health A 2009, 72(11-12):740-745.
33. Lin W.S., Huang Y.W., Zhou X.D., Ma Y.F. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 2006, 25(6):451-457.
34. Mocan T., Clichici S., Agoşton-Coldea L., Mocan L., Simon S., Ilie I.R., et al. Implications of oxidative stress mechanisms in toxicity of nanoparticles (review). Acta Physiol Hung 2010, 97(3):247-255.
35. Nakagawa Y., Suzuki T., Ishii H., Nakae D., Ogata A. Cytotoxic effects of hydroxylated fullerenes on isolated rat hepatocytes via mitochondrial dysfunction. Arch Toxicol 2011, 85(11):1429-1440.
36. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
37. Nesic O., Xu G.-Y., McAdoo D., Westlund High K., Hulsebosch C., Perez-Polo R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma 2004, 18(9):947-956.
38. Niu J., Azfer A., Rogers L.M., Wang X., Kolattukudy P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007, 73(3):549-559.
39. Niu J., Wang K., Kolattukudy P.E. Cerium oxide nanoparticles inhibits oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J Pharmacol Exp Ther 2011, 338(1):53-61.
40. Park E.J., Choi J., Park Y.K., Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 2008, 245(1-2):90-100.
41. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., et al. Glutathione-peroxidase, superoxide-dismutase, and catalase inactivation by peroxides and oxygen derived free-radicals. Mech Ageing Dev 1990, 51(3):283-297.
42. Pirmohamed T., Dowding J.M., Singh S., Wasserman B., Heckert E., Karakoti A.S., et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun 2010, 46(16):2736-2738.
43. Radu M., Munteanu M.C., Petrache S., Serban A.R., Dinu D., Hermenean A., et al. Depletion of intracellular glutathione and increased lipid peroxidation mediate cytotoxicity of hematite nanoparticles in MRC-5 cells. Acta Biochim Pol 2010, 57(3):355-360.
44. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 2009, 187(1):15-21.
45. Rzigalinski B.A., Meehan K., Davis R.M., Xu Y., Miles W.C., Cohen C.A. Radical nanomedicine. Nanomedicine (Lond) 2006, 1(4):399-412.
46. Sharma H.S., Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Progress in brain research 2007, vol. 162. Elsevier, p. 245-73.
47. Srinivas A., Rao P.J., Selvam G., Murthy P.B., Reddy P.N. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 2011, 205(2):105-115.
48. Sultana R., Piroddi M., Galli F., Butterfield D.A. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem Res 2008, 33(12):2540-2546.
49. Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., et al. Adriamycin-induced, TNF-α-mediated central nervous system toxicity. Neurobiol Dis 2006, 23(1):127-139.
50. Usenko C.Y., Harper S.L., Tanguay R.L. Fullerene C60 exposure elicits an oxidative stress response in embryonic zebrafish. Toxicol Appl Pharmacol 2008, 229(1):44-55.
51. Wang J., Rahman M.F., Duhart H.M., Newport G.D., Patterson T.A., Murdock R.C., et al. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30(6):926-933.
52. Wang J., Sun P., Bao Y., Liu J., An L. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol In Vitro 2011, 25(1):242-250.
53. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H., et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2(10):2121-2134.
54. Xia T., Li N., Nel A.E. Potential health impact of nanoparticles. Annu Rev Public Health 2009, 30(1):137-150.
55. 2, ZnO and their bulk counterparts on zebrafish: acute toxicity, oxidative stress and oxidative damage. Sci Total Environ 2011, 409(8):1444-1452.
56. Yokel R.A., Florence R.L., Unrine J.M., Tseng M.T., Graham U.M., Wu P., et al. Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial. Nanotoxicology 2009, 3(3):234-248.
57. Yokel R.A., Florence R.L., Unrine J.M., Tseng M.T., Graham U.M., Wu P., et al. Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial. Nanotoxicology 2009, 3(4):234-248.
58. Younce C.W., Wang K., Kolattukudy P.E. Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovasc Res 2010, 87(4):665-674.
59. Zhou X., Wong L.L., Karakoti A.S., Seal S., McGinnis J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the vldlr knockout mouse. PLoS One 2011, 6(2):e16733.